Literature DB >> 30421508

Effect of Hemodialysis on the Red Blood Cell Life Span in Patients with End-Stage Kidney Disease.

Jun-Feng Luo1, Jiu-Hong Li2, Jun-Jie Nie1, Ping-Ping Li1, Hou-De Zhang1,3, Yong-Jian Ma1.   

Abstract

The aim of this study was to use a CO breath test to investigate hemodialysis effects on red blood cell lifespan in patients with chronic kidney disease. A cohort of 17 non-smoking men with end-stage kidney disease undergoing hemodialysis via a polysulfone dialysis membrane (as opposed to a traditional cellulose acetate membrane) were subjected to a repeated Levitt's CO breath test to compare red blood cell lifespan before vs. after dialysis. None of the patients showed significant fluctuations in endogenous CO concentration during the dialysis procedure. The mean red blood cell lifespan was 66.0 ± 31.0 days before dialysis and 72.0 ± 26.0 days after dialysis, with no significant difference between the assessment time points (P > 0.05). In conclusion, dialysis using a polysulfone membrane did not appear to disrupt red blood cells or reduce their lifespan in patients with end-stage kidney disease.
© 2018 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.

Entities:  

Keywords:  Biocompatibility; Chronic kidney disease; Hemodialysis; Levitt's CO breath test; Red blood cell lifespan

Mesh:

Substances:

Year:  2018        PMID: 30421508     DOI: 10.1111/1744-9987.12775

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  1 in total

1.  Hemodiafiltration improves red blood cell lifespan in patients with end-stage renal disease.

Authors:  Ying Jiang; Jiu-Hong Li; Jun-Feng Luo; Quan-Sheng Han; Sheng-Lang Zhu; Yong-Jian Ma; Hou-De Zhang
Journal:  Semin Dial       Date:  2021-11-04       Impact factor: 2.886

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.